The year in review: A Mugglehead roundup

The year 2025 in review: A Mugglehead roundup

Blink and 2025 is going to be over. Pop the cork. Hallelujah.

The year was defined by a weird mix of volatility, breakthroughs, and sharp reminders of how fast technology, markets, and medicine can shift. Precious metals surged on global uncertainty as wars and violence made investors head for safe haven assets. Medical diagnostics and psychedelic therapies incorporated artificial intelligence and inched towards the mainstream.

Investor behavior told a similar story. In periods of ...

Continue Reading →
California governor signs bill to promote state psychedelics research

California governor signs bill to promote state psychedelics research

California Governor Gavin Newsom signed a bill to expedite research on psychedelic substances for mental health indications last week.

Assembly Bill 1103 also aims to facilitate studies on psychoactive compounds for treating traumatic brain injuries and substance use disorders. It prioritizes the well-being of state veterans suffering from these challenging indications.

Psilocybin, ibogaine and MDMA are expected to be key focuses. Authorizations for clinical research involving these controlled substances will become easier to obtain ...

Continue Reading →
Page 1 of 7 12345...»
UA-77446339-1